JP2021523375A5 - - Google Patents

Info

Publication number
JP2021523375A5
JP2021523375A5 JP2020563696A JP2020563696A JP2021523375A5 JP 2021523375 A5 JP2021523375 A5 JP 2021523375A5 JP 2020563696 A JP2020563696 A JP 2020563696A JP 2020563696 A JP2020563696 A JP 2020563696A JP 2021523375 A5 JP2021523375 A5 JP 2021523375A5
Authority
JP
Japan
Prior art keywords
als
subject
biomarker
level
lbp
Prior art date
Application number
JP2020563696A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019217916A5 (https=
JP2021523375A (ja
JP7371019B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/031858 external-priority patent/WO2019217916A1/en
Publication of JP2021523375A publication Critical patent/JP2021523375A/ja
Publication of JPWO2019217916A5 publication Critical patent/JPWO2019217916A5/ja
Publication of JP2021523375A5 publication Critical patent/JP2021523375A5/ja
Priority to JP2023179310A priority Critical patent/JP2023181255A/ja
Application granted granted Critical
Publication of JP7371019B2 publication Critical patent/JP7371019B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020563696A 2018-05-10 2019-05-10 疾病の予後と管理のための方法 Active JP7371019B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023179310A JP2023181255A (ja) 2018-05-10 2023-10-18 疾病の予後と管理のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862669915P 2018-05-10 2018-05-10
US62/669,915 2018-05-10
PCT/US2019/031858 WO2019217916A1 (en) 2018-05-10 2019-05-10 Methods for prognosis and management of disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023179310A Division JP2023181255A (ja) 2018-05-10 2023-10-18 疾病の予後と管理のための方法

Publications (4)

Publication Number Publication Date
JP2021523375A JP2021523375A (ja) 2021-09-02
JPWO2019217916A5 JPWO2019217916A5 (https=) 2022-05-18
JP2021523375A5 true JP2021523375A5 (https=) 2022-05-18
JP7371019B2 JP7371019B2 (ja) 2023-10-30

Family

ID=66655475

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020563696A Active JP7371019B2 (ja) 2018-05-10 2019-05-10 疾病の予後と管理のための方法
JP2023179310A Pending JP2023181255A (ja) 2018-05-10 2023-10-18 疾病の予後と管理のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023179310A Pending JP2023181255A (ja) 2018-05-10 2023-10-18 疾病の予後と管理のための方法

Country Status (8)

Country Link
US (1) US20210231686A1 (https=)
EP (1) EP3791188A1 (https=)
JP (2) JP7371019B2 (https=)
KR (1) KR20210014109A (https=)
CN (1) CN112424608A (https=)
AU (1) AU2019264996A1 (https=)
IL (1) IL278616B2 (https=)
WO (1) WO2019217916A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3612566A4 (en) * 2017-04-21 2021-03-03 Implicit Bioscience Limited CD14 ANTAGONIST ANTIBODIES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
CN113842449B (zh) * 2021-09-08 2024-02-23 乐卫东 枸杞糖肽在制备预防和/或治疗肌萎缩侧索硬化的药物中的应用
WO2025049671A1 (en) * 2023-08-30 2025-03-06 The Methodist Hospital Markers of amyotrophic lateral sclerosis survival and uses thereof
JPWO2025058005A1 (https=) * 2023-09-15 2025-03-20

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
AU667462B2 (en) * 1990-11-30 1996-03-28 Monoclonetics International Incorporated Methods for the diagnosis of chronic lower back and cervical pain
ATE335072T1 (de) 1993-05-28 2006-08-15 Scripps Research Inst Methoden für inhibition der cd14-abhängigen zellaktivierung
CA2319828A1 (en) 1998-01-29 1999-08-05 Miller, Samuel High density arrays for proteome analysis and methods and compositions therefor
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US20010041349A1 (en) 2000-04-17 2001-11-15 Andrew Patron Protein expression system arrays and use in biological screening
GB0022978D0 (en) 2000-09-19 2000-11-01 Oxford Glycosciences Uk Ltd Detection of peptides
AU2002220236A1 (en) 2000-11-09 2002-05-21 Bionova Pharmaceutials, Inc. A method for identifying the proteome of cells using an antibody library microarray
US7264967B2 (en) 2000-11-22 2007-09-04 Mochida Pharmaceutical Co., Ltd. Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR binding
EP1360490B1 (en) 2001-01-23 2011-12-21 President and Fellows of Harvard College Nucleic-acid programmable protein arrays
WO2003062444A2 (en) 2001-11-13 2003-07-31 Emory University Array systems and methods
US7030126B2 (en) * 2001-11-16 2006-04-18 Als Therapy Development Foundation, Inc. Use of polyamine analogs for amyotrophic lateral sclerosis
EP1502102B1 (en) 2002-03-11 2009-01-14 caprotec bioanalytics GmbH Compounds and methods for analyzing the proteome
US20070105105A1 (en) * 2003-05-23 2007-05-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
CA2566101C (en) * 2004-05-11 2013-05-21 Mochida Pharmaceutical Co., Ltd. Novel soluble cd14 antigen
CA2754741C (en) * 2009-03-11 2019-02-12 Augurex Life Sciences Corporation Compositions and methods for characterizing arthritic conditions
CN102573500A (zh) * 2009-08-06 2012-07-11 纽拉尔图斯制药公司 巨噬细胞相关疾病的治疗
US8465727B2 (en) 2009-10-06 2013-06-18 University of Pittsburgh—of the Commonwealth System of Higher Education Biomarkers for the diagnosis of ALS
EP2501720A2 (en) * 2009-11-18 2012-09-26 Lascco SA Ifn inhibitors in the treatment of motoneuron diseases
US20130230499A1 (en) * 2010-03-10 2013-09-05 Michal Eisenbach-Schwartz Cellular blood markers for early diagnosis of als and for als progression
WO2012004276A2 (en) * 2010-07-06 2012-01-12 Fondazione Telethon Multiprotein biomarkers of amyotrophic lateral sclerosis in peripheral blood mononuclear cells, diagnostic methods and kits
JP5801895B2 (ja) * 2011-08-12 2015-10-28 株式会社Ｌｓｉメディエンス 全身性炎症反応症候群を伴わない術後感染症の検出方法
CA2851280C (en) * 2011-10-11 2021-05-18 The Brigham And Women's Hospital, Inc. Micrornas in neurodegenerative disorders
WO2014102333A1 (en) * 2012-12-28 2014-07-03 Mitsubishi Chemical Medience Corporation Use of scd14 or its fragments or derivatives for risk stratisfaction, diagnosis and prognosis
CN106413721A (zh) * 2014-05-16 2017-02-15 纽拉尔图斯制药公司 用于治疗巨噬细胞相关病症的方法和组合物
WO2016083374A1 (en) * 2014-11-25 2016-06-02 F. Hoffmann-La Roche Ag Biomarkers of fast progression of chronic kidney disease
SG11201808671YA (en) * 2015-04-02 2018-11-29 Methodist Hospital Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity
EP3391057B1 (en) * 2015-12-16 2020-04-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infections
US11131676B2 (en) * 2016-02-25 2021-09-28 The Trustees Of Columbia University In The City Of New York Systemic immune activation and biomarkers of nonceliac wheat/gluten sensitivity
EP3612566A4 (en) 2017-04-21 2021-03-03 Implicit Bioscience Limited CD14 ANTAGONIST ANTIBODIES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
AU2024238511A1 (en) * 2023-03-21 2025-10-02 Coya Therapeutics, Inc. Biomarkers of amyotrophic lateral sclerosis and uses thereof

Similar Documents

Publication Publication Date Title
Awad et al. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
JP2021523375A5 (https=)
Yoo et al. Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis
TW201606307A (zh) 阿茲海默症及其他神經退化性疾病之生物標記及診斷方法
EP2836608A1 (en) Tuberculosis biomarkers and uses thereof
JP2014505259A (ja) 慢性心不全における予後診断および診断の方法
ES2690486T3 (es) Biomarcador de enfermedad renal crónica
Outinen et al. Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection
US20130210667A1 (en) Biomarkers for Predicting Kidney and Glomerular Pathologies
JP2018519499A (ja) 慢性腎疾患の発症のリスクを予測するための方法
CN110702917A (zh) 血清淀粉样蛋白p在制备抑郁症诊断治疗相关产品的用途
WO2023079150A1 (en) Biomarker panel for diagnosing pulmonary dysfunction
EP3287789A1 (en) Composition and kit for diagnosing behavioral addiction, and method of detecting neuropilin-2 for diagnosis of behavioral addiction
KR102328932B1 (ko) 신장이식 후 항체 매개성 거부반응의 진단 또는 예측을 위한 소변 엑소좀 바이오마커
CN108474798A (zh) 表征细胞特异性微囊泡的方法
JP2010014689A (ja) プロテオミクス解析を用いたメラノーママーカーの同定
JP2012526543A5 (https=)
KR20170115039A (ko) 가와사키병의 검사 방법 및 키트
CN119534864A (zh) 一种新型的IgG4相关性疾病的标志物及其应用
Alachkar Serum and urinary biomarkers in acute kidney transplant rejection
JPWO2019217916A5 (https=)
JP2021170021A (ja) 糖尿病性腎症の早期病態の特異的な診断を可能とする検査方法
WO2024023139A1 (en) Methods for prognosis and monitoring pulmonary hypertension
Ip et al. Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets
EP3682236A1 (en) Proadrenomedullin as indicator for renal replacement therapy in critically ill patients